News Avalanche Eye Gene Therapy Meets Safety Goal by Medscape • 2015/06/16 • 0 Comments Avalanche Biotechnologies Inc's experimental gene therapy for a leading cause of blindness met its primary safety goal in a small mid-stage trial, while staving off vision loss. Reuters Health Information Full Story →